ARK Genomic Revolution ETF Rating $44.53 +1.49 (+3.46%) As of 11:18 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock ARK Genomic Revolution ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.57Holdings in ARKG have an aggregate rating of Moderate Buy based on 338 analyst ratings issued in the past year covering 25 companies (94.5% of the portfolio).ARKG Aggregate Price Target$43.04High Prediction$43.04Average Prediction$43.04Low Prediction$43.04Holdings in ARKG have an aggregate price target of $43.04 and a range of $43.04 to $43.04 covering 25 companies (94.5% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 ARKG Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.03%TXG10x Genomics$56.20+8.0%1.8552 of 5 stars2.20$35.67 -36.5%15Earnings ReportAnalyst Forecast7.97%TWSTTwist Bioscience$124.05+7.2%1.4507 of 5 stars2.70$98.30 -20.8%10Earnings Report6.68%TEMTempus AI$55.75+7.1%3.4868 of 5 stars2.41$64.92 16.5%176.60%CRSPCRISPR Therapeutics$54.04+1.0%3.256 of 5 stars2.58$68.06 25.9%19Earnings ReportAnalyst UpgradeAnalyst Revision5.55%PSNLPersonalis$14.69+3.7%1.5546 of 5 stars2.22$14.25 -3.0%9Earnings Report5.32%ABSIAbsci$9.17+2.7%2.6115 of 5 stars2.78$13.43 46.4%9Negative NewsUpcoming Earnings4.45%ILMNIllumina$190.60+1.4%2.7495 of 5 stars2.47$188.40 -1.2%174.44%GHGuardant Health$169.40+0.5%2.8579 of 5 stars2.96$183.78 8.5%254.40%CDNACareDx$47.71+2.2%3.28 of 5 stars2.43$47.75 0.1%74.32%LLYEli Lilly and Company$1,213.68+2.4%4.1469 of 5 stars2.87$1,292.18 6.5%31Earnings ReportAnalyst Forecast4.03%NTRANatera$314.62-2.3%2.94 of 5 stars2.77$301.90 -4.0%22Earnings ReportAnalyst Forecast3.98%BEAMBeam Therapeutics$27.470.0%2.2161 of 5 stars2.69$49.00 78.4%13Positive NewsEarnings ReportAnalyst Downgrade3.21%CMPSCompass Pathways$13.24-2.2%3.0147 of 5 stars2.88$23.36 76.4%17Earnings ReportAnalyst Forecast2.75%RXRXRecursion Pharmaceuticals$3.31+2.6%1.9444 of 5 stars2.20$8.10 145.1%5Earnings ReportAnalyst Downgrade2.66%ADPTAdaptive Biotechnologies$25.75+3.3%1.3832 of 5 stars2.57$24.42 -5.2%72.56%BFLYButterfly Network$9.89+12.0%1.3348 of 5 stars2.40$5.56 -43.8%52.53%NRIXNurix Therapeutics$25.76+0.9%2.6098 of 5 stars2.80$34.00 32.0%15Analyst UpgradeGap Up2.42%VCYTVeracyte$46.40-1.7%3.9067 of 5 stars2.64$54.33 17.1%11Analyst Upgrade2.01%WGSGeneDx$77.17+0.1%3.5077 of 5 stars2.67$89.57 16.1%9Earnings ReportAnalyst Upgrade1.95%SDGRSchrodinger$18.53+2.0%1.614 of 5 stars2.33$20.25 9.3%9Earnings ReportAnalyst Upgrade1.84%NTLAIntellia Therapeutics$12.09+1.3%3.2642 of 5 stars2.35$20.85 72.5%23Positive NewsEarnings ReportAnalyst UpgradeAnalyst Revision1.78%IONSIonis Pharmaceuticals$57.34+1.4%3.7419 of 5 stars2.77$94.65 65.1%221.58%ALMRAlamar Biosciences$28.63+0.6%1.7687 of 5 stars2.67$30.00 4.8%61.37%PRMEPrime Medicine$3.20+3.7%2.9938 of 5 stars2.88$7.53 135.7%8Earnings ReportAnalyst Upgrade1.08%GENBGenerate Biomedicines$14.45+0.7%2.1084 of 5 stars2.86$25.40 75.8%7Earnings ReportAnalyst DowngradeGap Up This page (BATS:ARKG) was last updated on 8/10/2026 by MarketBeat.com Staff. From Our PartnersThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredFDA Clears This Under-$5 Biotech for Phase 2 Clinical TrialA NASDAQ-listed biotech just cleared a major FDA milestone. Its lead therapy, Lucid-MS, has been cleared for P...The Tomorrow Investor | SponsoredSpaceX is NOT the #1 IPO of 2026A lesser known AI company is growing faster than both SpaceX and OpenAI. Its coding business reportedly grew f...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredBuy this stock tomorrowA new strategy called Sell This, Buy That aims to help investors rotate out of overpriced AI stocks before a p...Chaikin Analytics | SponsoredThis Junior Silver Explorer Is Closing In on Its Biggest CatalystA past-producing Nevada silver project holds a historical 36 million ounce silver-equivalent resource, plus mo...Wall Street Logic | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARKG Stock Alerts